AID Diagnostika

AID Diagnostika

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AID Diagnostika is a long-established, privately-held diagnostics company focused on immunology and infectious disease testing. It has built a business around manufacturing and selling its own diagnostic kits and complementary imaging/analysis systems, indicating a vertically integrated approach within its niche. The company appears to be in a stable, revenue-generating commercial stage, leveraging its decades of experience in a consistently relevant diagnostic sector. Its private status and specific focus suggest a specialized, steady-state operation rather than a high-growth biotech venture.

Infectious DiseaseImmunology

Technology Platform

Integrated diagnostic platform combining immunological assay kits (e.g., ELISA, IFA, immunoblot) with proprietary imaging devices and analysis software for end-to-end workflow solutions in clinical laboratories.

Opportunities

Growth is driven by the perennial demand for infectious and autoimmune disease testing, the need for IVDR-compliant products in Europe, and potential geographic expansion.
The integrated systems approach (assay + instrument + software) creates recurring revenue and customer loyalty.

Risk Factors

Key risks include navigating the costly and complex new EU IVD Regulation (IVDR), intense competition from large multinational diagnostics corporations, and technological disruption from newer diagnostic methodologies that could render existing platforms obsolete.

Competitive Landscape

AID Diagnostika competes in a fragmented but competitive segment against giant diversified players (Roche, Abbott, Siemens) and other specialized immunology diagnostics firms. It differentiates through a focused product portfolio, integrated systems, and deep niche expertise, but faces constant pressure from larger competitors' scale and R&D resources.